Inhibition of the MAPK pathway alone is insufficient to account for all of the cytotoxic effects of naringenin in MCF-7 breast cancer cells

Estrogen receptor (ER) antagonists such as tamoxifen (Tam) have been used successfully to treat ER+ breast cancers for more than 30 years. Unfortunately, long term use of Tam can result in resistance. Tam resistance is associated with the activation of growth factor signaling pathways that promote c...

Descripción completa

Detalles Bibliográficos
Autores principales: Eanes, Lauren, Patel, Yashomati M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801822/
https://www.ncbi.nlm.nih.gov/pubmed/29450133
http://dx.doi.org/10.1016/j.biopen.2016.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801822/
https://www.ncbi.nlm.nih.gov/pubmed/29450133
http://dx.doi.org/10.1016/j.biopen.2016.09.004

Ejemplares similares